A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61K 31/40 (2006.01) A61K 31/435 (2006.01) A61K 31/438 (2006.01) A61K 31/439 (2006.01) A61K 31/451 (2006.01) A61K 31/453 (2006.01) A61K 31/454 (2006.01) A61K 31/4709 (2006.01) A61K 31/496 (2006.01) A61K 31/5377 (2006.01) A61K 31/538 (2006.01) A61K 38/17 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 25/00 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2324813
The present invention relates to a method of treating depression or anxiety in a mammal, including a human, by administering to the mammal a CNS-penetrant NK-1 receptor antagonist e.g., a substance P receptor antagonist) in combination with an antidepressant or an anxiolytic agent. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a CNS-penetrant NK-1 receptor antagonist and an anxiolytic agent or antidepressant.
Bereskin & Parr
Pfizer Products Inc.
LandOfFree
Combination treatment for depression and anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination treatment for depression and anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination treatment for depression and anxiety will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1511978